Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 29, 1996

View Archived Issues

Merck & Co. describes new compounds for dopamine-related disorders

New bombesin analogues from Biomeasure

Takeda describes antiprotozoal agents

Novel nonmacrolide antitumor agent discovered by Mitsubishi

Takeda discloses natural ET receptor antagonist

New serotoninergic drugs from E. Merck

Univ. of Washington offers human topo I-producing system for licensing

Discovery related to pharmacological screening and gene mapping available for licensing

Univ. of Washington offers cell line for screening compounds

Animal model for testing osteoporotic therapies available for licensing

Locus control region for transgenic expression available for licensing

3DP seeks partners for protease inhibitor discovery program

Partners sought for 3DP MHC blockers

3DP seeks partners for potential treatments for retinopathies and cancer

Corporate partners sought for drug discovery collaboration based on 3DP technology

3DP seeks partners for receptor-based drug discovery program

Anticancer compound from AEterna enters the clinic

Negative clinical results reported for aromatase inhibitor in BPH

Sorin to market Bard diagnostic test

DepoTech begins filing NDA for DepoCyt

Harvard Scientific seeks to proceed with clinical trials on erectile dysfunction Rx

Avigen reports successful gene therapy with EPO

Vertex compound effective in rat model of nerve injury

CytoTherapeutics and Genentech sign new CNS therapeutics agreement

Vasogen autocellular response therapy appears effective in RA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...